Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Alkem Labs gets 2 USFDA observations for Daman facility

      Alkem Labs gets 2 USFDA observations for Daman facility

      Medical Dialogues Bureau31 Aug 2019 12:32 PM IST
      New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received two observations from the US health regulator for...
      Aurobindo Pharma, Shanghai LongJin sign deal to form JV in China

      Aurobindo Pharma, Shanghai LongJin sign deal to form JV in China

      Medical Dialogues Bureau31 Aug 2019 11:17 AM IST
      The joint venture is for development, manufacturing, marketing and sale of pharmaceutical products for China, excluding Taiwan, Hongkong and Macau,...
      Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

      Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

      Medical Dialogues Bureau31 Aug 2019 9:30 AM IST
      Alimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
      Dr Abhinay named as new CEO of KIMS Hospitals

      Dr Abhinay named as new CEO of KIMS Hospitals

      Medical Dialogues Bureau31 Aug 2019 9:00 AM IST
      In his previous role as Vice-President, Dr Abhinay oversaw Business Development and Strategy for KIMS Hospitals, a statement said.Hyderabad:...
      Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

      Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

      Medical Dialogues Bureau30 Aug 2019 2:57 PM IST
      These intelligence cells will work in coordination with the officers of state drug departments and the Central Drug Control Standard Organisation...
      Lantech Pharma gets USFDA warning letter for deviations from CGMP at Andhra plant

      Lantech Pharma gets USFDA warning letter for deviations from CGMP at Andhra plant

      Medical Dialogues Bureau30 Aug 2019 10:00 AM IST
      "This warning letter summarises significant deviations from CGMP for active pharmaceutical ingredients (API)..because your methods, facilities, or...
      Granules India to sell entire stake in Granules OmniChem to JV Ajinomoto

      Granules India to sell entire stake in Granules OmniChem to JV Ajinomoto

      Medical Dialogues Bureau30 Aug 2019 9:45 AM IST
      GOC is an equal joint venture between Granules India and S A Ajinomoto Omnichem NV (now doing business as Ajinomoto Bio-Pharma Services), an...
      Medtronic CEO Omar Ishrak to step down in 2020, Geoff Martha to take over

      Medtronic CEO Omar Ishrak to step down in 2020, Geoff Martha to take over

      Medical Dialogues Bureau30 Aug 2019 9:17 AM IST
      Omar Ishrak, who will turn 65 next year, will continue to be the chairman of the board, the company said. Before joining Medtronic as CEO in 2011,...
      Roche Tecentriq wins European nod for breast cancer

      Roche Tecentriq wins European nod for breast cancer

      Medical Dialogues Bureau30 Aug 2019 9:15 AM IST
      The European Commission approved Tecentriq with Abraxane for people with metastatic triple-negative breast cancer that tests positive for a protein...
      Sterling Biotech case: ED records statement of Ahmed Patels son Faisal

      Sterling Biotech case: ED records statement of Ahmed Patel's son Faisal

      Medical Dialogues Bureau29 Aug 2019 4:57 PM IST
      NEW DELHI: The ED has recorded the statement of Faisal Patel, son of senior Congress leader Ahmed Patel, in connection with its probe into the alleged...
      Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

      Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

      Medical Dialogues Bureau29 Aug 2019 4:10 PM IST
      New Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
      USFDA grants orphan drug status to AstraZenecas asthma drug Fasenra

      USFDA grants orphan drug status to AstraZeneca's asthma drug Fasenra

      Medical Dialogues Bureau29 Aug 2019 3:57 PM IST
      AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok